The first cells Siddhartha Mukherjee ever saw were T cells, pulled from a mouse spleen and plated onto the microscope slide, given chemicals to coax them to grow. When he looked down the scope, he was struck by the life in them, marveling at what he called their “inner glow and luminous fullness.”
That thrill Mukherjee feels each time he sees life under the microscope carries into his new book, “The Song of the Cell.” The book is at once a kind of freewheeling adventure through the history of the cell — from the first microscopes to the highly engineered CAR-T cells that cured once “incurable” leukemia patients — and a personal reflection on human health, disease, and the rapid pace of cellular medicine.
“The excitement of this world is the excitement of those therapies and how it could be actualized,” Mukherjee said. “I, myself, have been doing a lot of work on cellular therapies and genetically modifying cells. So there’s been a range of really exciting changes in cell therapy that I’ve witnessed that have also gotten in this book.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect